Primary PreventionNCT04307745
Primary Prevention Habits for the Shoulder: Survey of the Sportsman's Entourage
An observational study of Primary Prevention and Shoulder, run by University of Liege at 1 site in Belgium.
Trial summary
Purpose: To provide an update on the implementation of prevention among overhead athletes by their entourage. Materiel and method: This study will be conducted by the means of a questionnaire. The target population consisted of doctors, trainers, physical trainer and physiotherapist. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Primary Prevention, Shoulder, Questionnaire and Survey
- What is being tested?
- Primary prevention
- How many people
- 213 participants
- Where
- 1 siteBelgium
- Study dates
- 5 Jun 2020to 15 Dec 2020
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: The population will be physiotherapist, doctor, trainer and physical trainer who are one contact with athletes (upper limb athletes).
Who may be able to join
- Professions: physiotherapist, doctor, trainer or physical trainer
Who cannot join
- Other professions
Trial locations and contacts
1 site in 1 country.
About this study
Purpose: To provide an update on the implementation of prevention among overhead athletes by their entourage.
Materiel and method: This study will be conducted by the means of a questionnaire. The target population consisted of doctors, trainers, physical trainer and physiotherapist.
The questionnaire will be validated by experts in each categorie and published on an online survey website
- Conditions
- Primary Prevention, Shoulder, Questionnaire and Survey
- Being tested
- Primary prevention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Primary preventionOther
The primary prevention that the 4 groups put in place for the upper limp athletes
| Study group | Role | What they receive |
|---|---|---|
| Physiotherapist | Not described Receives: Other: Primary prevention | |
| Doctor | Not described Receives: Other: Primary prevention | |
| Physical trainer | Not described Receives: Other: Primary prevention | |
| Trainer | Not described Receives: Other: Primary prevention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Primary prevention of the shoulder
Measured: The questionnaire will last 15 minutes at most
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Mar 2020
- Study start5 Jun 2020
- Primary completion15 Dec 2020
- Study completion15 Dec 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Primary PreventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 213 participants (actual)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- University of Liege
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gofflot Amandine, University of Liege
- Investigators
- Amandine Gofflot, Principal investigator, ULiège
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04307745
- Sponsor's protocol ID
- 1604
- Status last verified
- Nov 2020
- First submitted
- 10 Mar 2020
- Last updated
- 3 Feb 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Feb 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Primary Prevention Habits for the Shoulder: Survey of the Sportsman's Entourage
- ClinicalTrials.gov ID
- NCT04307745
- Acronym / sponsor ID
- 1604
- Conditions
- Primary Prevention, Shoulder, Questionnaire and Survey
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 213 participants (actual)
- Lead sponsor
- University of LiegeUniversity, hospital or other
- Study start
- 5 Jun 2020 (actual)
- Primary completion
- 15 Dec 2020 (actual)
- Study completion
- 15 Dec 2020 (actual)
- First posted
- 13 Mar 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose: To provide an update on the implementation of prevention among overhead athletes by their entourage.
Materiel and method: This study will be conducted by the means of a questionnaire. The target population consisted of doctors, trainers, physical trainer and physiotherapist.
The questionnaire will be validated by experts in each categorie and published on an online survey website
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Target follow-up
- 6 Months
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Physiotherapist | – | Other: Primary prevention |
| Doctor | – | Other: Primary prevention |
| Physical trainer | – | Other: Primary prevention |
| Trainer | – | Other: Primary prevention |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- The population will be physiotherapist, doctor, trainer and physical trainer who are one contact with athletes (upper limb athletes).
Key inclusion criteria (1 listed)
- Professions: physiotherapist, doctor, trainer or physical trainer
Key exclusion criteria (1 listed)
- Other professions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Primary preventionThe primary prevention that the 4 groups put in place for the upper limp athletes | Other | Doctor, Physical trainer, Physiotherapist, Trainer |
Primary outcome
Primary prevention of the shoulder
Time frame: The questionnaire will last 15 minutes at most
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Feb 2021.
Related trials for Primary Prevention
Not yet recruitingObservational study
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Abdominal Aortic Aneurysm, Morbid Obesity
Not yet recruiting
Is Routine Dental Clearance or Antibiotic Prophylaxis Before Dental Procedures Necessary in Total Joint Arthroplasty?
Elective Primary THA or TKA
Recruiting
Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)
Cardiovascular Risk, Genetic Cardiovascular Risk
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Enrolling by invitation
The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary Prevention
Coronary Atherosclerosis and Other Heart Disease, Cardiovascular Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Amandine Gofflot principal investigator
ULiège
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Primary Prevention and Shoulder, run by University of Liege at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Primary prevention of the shoulder (time frame: The questionnaire will last 15 minutes at most). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2021.